IJMS | Free Full-Text | Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties | Aging
Neatsy wants to reduce sneaker returns with 3D foot scans | TechCrunch
HAUSER Puma 16 Gyerek Kerékpár - Gyermek kerékpár árak - Kirakat a leggyorsabb árösszehasonlító
The Boring Co.'s 'Initial Hat Offering' raises $300K for digging in hat sales | TechCrunch